SAN DIEGO — Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A new study from the University of North Carolina has helped doctors and patients better understand which medications are ...

MELBOURNE, Australia — The use of IDegLira, a fixed-ratio combination of the glucagonlike peptide (GLP)-1 receptor agonist liraglutide (Victoza, Novo Nordisk) and insulin degludec (Tresiba, Novo ...

Although T2D hospitalization rates were nearly identical across treatment groups, risk for subsequent hospitalization was lower with liraglutide vs glimepiride. Among people with type 2 diabetes (T2D) ...

Share on Pinterest A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.

Medically reviewed by Erika Prouty, PharmD Key Takeaways Metformin helps control blood sugar by reducing glucose absorption, production, and increasing insulin sensitivity.Metformin is a popular first ...